These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2386943)
1. Androgen receptor gene expression in human prostate carcinoma cell lines. Tilley WD; Wilson CM; Marcelli M; McPhaul MJ Cancer Res; 1990 Sep; 50(17):5382-6. PubMed ID: 2386943 [TBL] [Abstract][Full Text] [Related]
2. DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. Alimirah F; Chen J; Basrawala Z; Xin H; Choubey D FEBS Lett; 2006 Apr; 580(9):2294-300. PubMed ID: 16580667 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
4. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus. Jia L; Coetzee GA Cancer Res; 2005 Sep; 65(17):8003-8. PubMed ID: 16140973 [TBL] [Abstract][Full Text] [Related]
6. Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines. Pignon JC; Koopmansch B; Nolens G; Delacroix L; Waltregny D; Winkler R Cancer Res; 2009 Apr; 69(7):2941-9. PubMed ID: 19318561 [TBL] [Abstract][Full Text] [Related]
7. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer. Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593 [TBL] [Abstract][Full Text] [Related]
8. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Henttu P; Vihko P Cancer Res; 1993 Mar; 53(5):1051-8. PubMed ID: 7679946 [TBL] [Abstract][Full Text] [Related]
10. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP. Fujinami K; Uemura H; Ishiguro H; Kubota Y Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554 [TBL] [Abstract][Full Text] [Related]
11. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis. Herness EA; Naz RK Cancer Res; 2003 Jan; 63(2):329-36. PubMed ID: 12543784 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells. Wang LG; Liu XM; Kreis W; Budman DR Cancer Res; 1997 Feb; 57(4):714-9. PubMed ID: 9044850 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. Eder IE; Culig Z; Ramoner R; Thurnher M; Putz T; Nessler-Menardi C; Tiefenthaler M; Bartsch G; Klocker H Cancer Gene Ther; 2000 Jul; 7(7):997-1007. PubMed ID: 10917202 [TBL] [Abstract][Full Text] [Related]
14. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells. Sadar MD; Gleave ME Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line. Tepper CG; Boucher DL; Ryan PE; Ma AH; Xia L; Lee LF; Pretlow TG; Kung HJ Cancer Res; 2002 Nov; 62(22):6606-14. PubMed ID: 12438256 [TBL] [Abstract][Full Text] [Related]
16. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Jarrard DF; Kinoshita H; Shi Y; Sandefur C; Hoff D; Meisner LF; Chang C; Herman JG; Isaacs WB; Nassif N Cancer Res; 1998 Dec; 58(23):5310-4. PubMed ID: 9850055 [TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of human androgen receptor (hAR) gene in prostate cancer cell lines PC-EW and PC-OR. Engehausen DG; Krause FS; Fleischmann J; Akcetin Z; Schrott KM; Endele S Anticancer Res; 2005; 25(3A):1611-4. PubMed ID: 16033069 [TBL] [Abstract][Full Text] [Related]
18. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype. Hobisch A; Ramoner R; Fuchs D; Godoy-Tundidor S; Bartsch G; Klocker H; Culig Z Clin Cancer Res; 2001 Sep; 7(9):2941-8. PubMed ID: 11555613 [TBL] [Abstract][Full Text] [Related]
19. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464 [TBL] [Abstract][Full Text] [Related]
20. DNA methylation in the androgen receptor gene promoter region in rat prostate cancers. Takahashi S; Inaguma S; Sakakibara M; Cho YM; Suzuki S; Ikeda Y; Cui L; Shirai T Prostate; 2002 Jun; 52(1):82-8. PubMed ID: 11992622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]